Published in J Clin Oncol on August 20, 2005
The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ. Br J Cancer (2008) 0.95
Genetic predisposition to in situ and invasive lobular carcinoma of the breast. PLoS Genet (2014) 0.95
Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues. Breast Cancer Res Treat (2011) 0.94
Acceptance and adherence to chemoprevention among women at increased risk of breast cancer. Breast (2014) 0.90
Germline CDH1 mutations in bilateral lobular carcinoma in situ. Br J Cancer (2013) 0.88
Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat (2013) 0.84
Trends in the distribution of breast cancer over time in the southeast of Scotland and review of the literature. Ecancermedicalscience (2014) 0.81
Non-operative breast pathology: lobular neoplasia. J Clin Pathol (2006) 0.81
Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk. J Clin Oncol (2015) 0.81
Concurrent breast stroma sarcoma and breast carcinoma: a case report. J Med Case Rep (2010) 0.80
The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden. Breast Cancer Res (2016) 0.80
Impact of preventive therapy on the risk of breast cancer among women with benign breast disease. Breast (2015) 0.79
Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer. Breast Cancer (Auckl) (2016) 0.77
Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy. Eur Radiol (2014) 0.77
Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast Cancer. Breast Care (Basel) (2010) 0.77
Lobular neoplasia detected in MRI-guided core biopsy carries a high risk for upgrade: a study of 63 cases from four different institutions. Mod Pathol (2015) 0.76
Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry. J Cancer Res Clin Oncol (2015) 0.76
What is atypical lobular hyperplasia and what does it mean for the patient? J Clin Oncol (2005) 0.76
Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review. Oncol Lett (2016) 0.75
Choices for young women at intermediate risk of breast cancer. Curr Oncol (2012) 0.75
Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases. Radiat Oncol (2015) 0.75
PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression. Breast Cancer Res (2017) 0.75
Clonal relationships between lobular carcinoma in situ and other breast malignancies. Breast Cancer Res (2016) 0.75
Bilateral invasive lobular breast cancer in a female teenager: a rare finding of a common disease--case report and review of literature. Pan Afr Med J (2010) 0.75
Awareness and current knowledge of breast cancer. Biol Res (2017) 0.75
Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ. Cancer Prev Res (Phila) (2017) 0.75
Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43
High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation (2007) 4.36
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy. Blood (2014) 2.94
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49
Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions. Blood (2004) 2.39
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia. Blood (2012) 2.27
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol (2005) 2.27
Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev (2004) 2.19
Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res (2006) 2.06
Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood (2006) 2.02
Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis (2007) 1.94
Organochlorines in carpet dust and non-Hodgkin lymphoma. Epidemiology (2005) 1.89
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys (2002) 1.82
Comparison of pesticide levels in carpet dust and self-reported pest treatment practices in four US sites. J Expo Anal Environ Epidemiol (2004) 1.76
The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population. J Allergy Clin Immunol (2012) 1.76
Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest (2005) 1.65
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood (2007) 1.63
Effect of antibiotics on vulvovaginal candidiasis: a MetroNet study. J Am Board Fam Med (2008) 1.61
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58
Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood (2010) 1.56
Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma. Cancer Res (2005) 1.55
Osteosarcoma as a second malignant neoplasm. Radiother Oncol (2002) 1.54
Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One (2009) 1.52
Ethnic differences in survival among women with ovarian carcinoma. Cancer (2002) 1.40
Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control (2006) 1.38
Diagnostic X-rays and ultrasound exposure and risk of childhood acute lymphoblastic leukemia by immunophenotype. Cancer Epidemiol Biomarkers Prev (2002) 1.38
Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol (2005) 1.36
Cancer among Arab Americans in the metropolitan Detroit area. Ethn Dis (2004) 1.35
Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer (2004) 1.32
Residential herbicide use and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2005) 1.24
Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control (2005) 1.20
Census and geographic differences between respondents and nonrespondents in a case-control study of non-Hodgkin lymphoma. Am J Epidemiol (2007) 1.20
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev (2009) 1.17
Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res (2007) 1.17
Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum (2005) 1.16
Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis (2006) 1.16
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study. Cancer (2010) 1.12
Violent victimization of women and men: physical and psychiatric symptoms. J Am Board Fam Pract (2003) 1.11
Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis. Arch Pediatr Adolesc Med (2009) 1.10
A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma. Environ Health Perspect (2011) 1.10
Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors. Int J Radiat Oncol Biol Phys (2002) 1.08
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis (2008) 1.08
Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control (2002) 1.07
Computer aided diagnostic tools aim to empower rather than replace pathologists: Lessons learned from computational chess. J Pathol Inform (2011) 1.06
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia. Blood (2002) 1.05
Residential insecticide use and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev (2006) 1.05
Breast cancer screening barriers and mammography completion in older minority women. Breast Cancer Res Treat (2005) 1.04
Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control (2007) 1.04
Metabolic gene variants and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev (2006) 1.03
Exploring physician and staff perceptions of the learning environment in ambulatory residency clinics. Fam Med (2006) 1.01
Analysis of Environmental Chemical Mixtures and Non-Hodgkin Lymphoma Risk in the NCI-SEER NHL Study. Environ Health Perspect (2015) 1.00
Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer (2002) 0.99
Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies. Br J Haematol (2011) 0.98
c-Kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol (2003) 0.97
Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer. Dig Dis Sci (2006) 0.97
Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence. Pediatr Hematol Oncol (2003) 0.96
Environmental determinants of polychlorinated biphenyl concentrations in residential carpet dust. Environ Sci Technol (2013) 0.96
Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan. Cancer Causes Control (2005) 0.94
Cutaneous melanoma in childhood and adolescence. Pediatr Hematol Oncol (2002) 0.94
Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma. Int J Cancer (2005) 0.93
Reproductive outcomes in male childhood cancer survivors: a linked cancer-birth registry analysis. Arch Pediatr Adolesc Med (2009) 0.93
Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood (2008) 0.92
Birth order and risk of non-hodgkin lymphoma--true association or bias? Am J Epidemiol (2010) 0.91
Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study. Int J Cancer (2008) 0.90
Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma. Cancer Causes Control (2009) 0.90
Automated area calculation of histopathologic features using SIVQ. Anal Cell Pathol (Amst) (2011) 0.89
Integration of architectural and cytologic driven image algorithms for prostate adenocarcinoma identification. Anal Cell Pathol (Amst) (2012) 0.89
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies. Br J Haematol (2010) 0.89
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood (2012) 0.89
Genetic polymorphisms in mediators of inflammation and gastric precancerous lesions. Eur J Cancer Prev (2008) 0.88
Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2010) 0.88
Multiple primary tumors in men with breast cancer diagnoses: a SEER database review. J Surg Oncol (2009) 0.88
Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma. Cancer Genet (2012) 0.87
Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Int J Cancer (2010) 0.87
Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation. Oncologist (2008) 0.86
Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer. Cancer Epidemiol (2010) 0.86
Association of dietary quercetin with reduced risk of proximal colon cancer. Nutr Cancer (2012) 0.86
Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men. Urol Oncol (2006) 0.85
Cyclin D1 splice variant and risk for non-Hodgkin lymphoma. Hum Genet (2006) 0.85
Dietary fatty acids, luminal modifiers, and risk of colorectal cancer. Int J Cancer (2010) 0.85
Genetic polymorphisms in anti-inflammatory cytokine signaling and the prevalence of gastric precancerous lesions in Venezuela. Cancer Causes Control (2006) 0.85
Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat (2006) 0.84
US appearance of the rotator cable with histologic correlation: preliminary results. Radiology (2006) 0.84
Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program registry: has outcome improved? (United States). Cancer Causes Control (2003) 0.83
Host-bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela. Int J Cancer (2006) 0.83
Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst (2004) 0.82
HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission. AIDS Res Ther (2006) 0.82
Cellular telephones and non-Hodgkin lymphoma. Int J Cancer (2006) 0.81
Role of radiation therapy in the management of locally advanced pancreatic cancer. J Clin Oncol (2012) 0.81